Burning Rock Biotech Ltd Quarterly Retained Earnings (Accumulated Deficit) in CNY from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: CNY and USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Burning Rock Biotech Ltd quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2019 to Q4 2023.
  • Burning Rock Biotech Ltd Retained Earnings (Accumulated Deficit) for the quarter ending December 31, 2023 was -¥3.85B, a 20.4% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (CNY)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 -3.85B -654M -20.4% Dec 31, 2023 20-F 2024-04-29
Q4 2022 -3.2B -971M -43.6% Dec 31, 2022 20-F 2024-04-29
Q2 2022 -2.75B Jun 30, 2022 6-K 2022-11-07
Q4 2021 -2.23B -811M -57.2% Dec 31, 2021 20-F 2023-04-20
Q4 2020 -1.42B -472M -49.8% Dec 31, 2020 20-F 2022-04-29
Q4 2019 -946M Dec 31, 2019 20-F 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.